Gravity sedimentation reveals functionally and morphologically different platelets in human blood.

Alpha granule immature platelet impedance aggregometry platelet volume

Journal

Platelets
ISSN: 1369-1635
Titre abrégé: Platelets
Pays: England
ID NLM: 9208117

Informations de publication

Date de publication:
Dec 2024
Historique:
medline: 8 1 2024
pubmed: 8 1 2024
entrez: 8 1 2024
Statut: ppublish

Résumé

In contrast to red blood cells, platelets float rather than sediment when a column of blood is placed in the gravitational field. By the analogy of erythrocyte sedimentation (ESR), it can be expressed with the platelet antisedimentation rate (PAR), which quantitates the difference in platelet count between the upper and lower halves of the blood column after 1 h of 1 g sedimentation. Venous blood samples from 21 healthy subjects were analyzed for PAR. After a 1-h sedimentation, the upper and lower fractions of blood samples were analyzed for platelet count, mean platelet volume (MPV), immature platelet fraction (IPF), and high-fluorescence IPF (H-IPF). The mechanisms behind platelet flotation were explored by further partitioning of the blood column, time-dependent measurements of platelet count and comparison with ESR. The structure and function of the platelets were assessed by electron microscopy (EM) and atomic force microscopy (AFM), and platelet aggregometry, respectively. Platelet antisedimentation is driven by density differences and facilitated by a size-exclusion mechanism caused by progressive erythrocyte sedimentation. The area under the curve (AUC) of the whole blood adenosine diphosphate (ADP) aggregation curves showed significant differences between the upper and lower samples ( It is less known that platelets do not sediment in response to gravitational force but float on the top of the blood column. This phenomenon is called antisedimentation, the rate of which, however, can be different, yet this feature has not been widely studied and used in clinical practice or diagnosis. We tested the idea that antisedimentation of platelets from venous blood samples can be a potential biomarker. We have found that platelet antisedimentation is driven by density differences and facilitated by a size-exclusion mechanism caused by progressive erythrocyte sedimentation and after 1-h upper and lower fractions develop. Interestingly, the aggregation curves showed significant differences between the upper and lower samples, suggesting that the ascending platelets show ex vivo hyperaggregability. Electron and atomic force microscopy revealed that platelets in the upper samples were larger in volume and contained more alpha granules than platelets in the lower samples. Subsequently, antisedimentation can be used to differentiate platelet populations based on their structural and functional properties; thus, it may be a promising biomarker for various thromboinflammatory disorders.

Autres résumés

Type: plain-language-summary (eng)
It is less known that platelets do not sediment in response to gravitational force but float on the top of the blood column. This phenomenon is called antisedimentation, the rate of which, however, can be different, yet this feature has not been widely studied and used in clinical practice or diagnosis. We tested the idea that antisedimentation of platelets from venous blood samples can be a potential biomarker. We have found that platelet antisedimentation is driven by density differences and facilitated by a size-exclusion mechanism caused by progressive erythrocyte sedimentation and after 1-h upper and lower fractions develop. Interestingly, the aggregation curves showed significant differences between the upper and lower samples, suggesting that the ascending platelets show ex vivo hyperaggregability. Electron and atomic force microscopy revealed that platelets in the upper samples were larger in volume and contained more alpha granules than platelets in the lower samples. Subsequently, antisedimentation can be used to differentiate platelet populations based on their structural and functional properties; thus, it may be a promising biomarker for various thromboinflammatory disorders.

Identifiants

pubmed: 38186228
doi: 10.1080/09537104.2023.2298341
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2298341

Auteurs

Erzsébet Ezer (E)

Department of Anesthesiology and Intensive Care, Medical School, University of Pecs, Pecs, Hungary.

Diana Schrick (D)

Department of Anesthesiology and Intensive Care, Medical School, University of Pecs, Pecs, Hungary.

Margit Tőkés-Füzesi (M)

Department of Laboratory Medicine, University of Pecs, Pecs, Hungary.

István Papp (I)

Department of Laboratory Medicine, University of Pecs, Pecs, Hungary.

Barbara Réger (B)

Department of Laboratory Medicine, University of Pecs, Pecs, Hungary.

Abigél Molnár (A)

Department of Medical Biology and Central Electron Microscopic Laboratory, University of Pecs Medical School, Pecs, Hungary.

Hajnalka Ábrahám (H)

Department of Medical Biology and Central Electron Microscopic Laboratory, University of Pecs Medical School, Pecs, Hungary.

Akos Koller (A)

Department of Neurosurgery, Medical School, University of Pecs, Pecs, Hungary.
Department of Morphology and Physiology, Faculty of Health Sciences, Semmelweis University, Budapest, Hungary.

Jolán Hársfalvi (J)

Department of Biophysics and Radiation Biology, Faculty of Medicine,Semmelweis University, Budapest, Hungary.

Miklós Kellermayer (M)

Department of Biophysics and Radiation Biology, Faculty of Medicine,Semmelweis University, Budapest, Hungary.
HUN-REN Biophysical Virology Research Group, Semmelweis University, Budapest, Hungary.

Tihamér Molnár (T)

Department of Anesthesiology and Intensive Care, Medical School, University of Pecs, Pecs, Hungary.

Classifications MeSH